Investigational Drug Information for Ruzasvir
✉ Email this page to a colleague
What is the development status for investigational drug Ruzasvir?
Ruzasvir is an investigational drug.
There have been 10 clinical trials for Ruzasvir.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 28th 2015.
The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, and Hepatitis A. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Atea Pharmaceuticals, Inc., and [disabled in preview].
There are two US patents protecting this investigational drug and thirty-three international patents.
Summary for Ruzasvir
| US Patents | 2 |
| International Patents | 33 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2015-01-28) |
| Vendors | 7 |
Recent Clinical Trials for Ruzasvir
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV | Atea Pharmaceuticals, Inc. | Phase 2 |
| Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir | Atea Pharmaceuticals, Inc. | Phase 1 |
| Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041) | Merck Sharp & Dohme Corp. | Phase 2 |
Clinical Trial Summary for Ruzasvir
Top disease conditions for Ruzasvir
Top clinical trial sponsors for Ruzasvir
US Patents for Ruzasvir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Ruzasvir | ⤷ Try a Trial | Process for preparing substituted tetracyclic heterocycle compounds | Merck Sharp & Dohme Corp. (Rahway, NJ) | ⤷ Try a Trial |
| Ruzasvir | ⤷ Try a Trial | Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases | Merck Sharp & Dohme Corp. (Rahway, NJ) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Ruzasvir
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Ruzasvir | World Intellectual Property Organization (WIPO) | WO2016196932 | 2035-06-04 | ⤷ Try a Trial |
| Ruzasvir | Argentina | AR094496 | 2033-01-16 | ⤷ Try a Trial |
| Ruzasvir | Australia | AU2013374112 | 2033-01-16 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
